DB550 |
Catalog No.GC35813 |
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
DB550 targets PLCγ1 and disrupts the CD95-PLCγ 1 interaction to prevent Th17-driven inflammation, without affecting the CD95-FADD interaction[1]. PLCγ1[1].
[1]. Poissonnier A, et al. Disrupting the CD95-PLCγ1 interaction prevents Th17-driven inflammation. Nat Chem Biol. 2018 Dec;14(12):1079-1089.
Review for DB550
Average Rating: 5
(Based on Reviews and 4 reference(s) in Google Scholar.)Review for DB550
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *